Research
Mixed
DNA methylation biomarkers in blood (e.g., ANK1, DAPK1, BDNF) are associated with Alzheimer's Disease (AD) risk and neuropathology, potentially enabling earlier detection.
If you have a family history of Alzheimer's, discuss emerging blood-based epigenetic biomarkers with your doctor. While not yet standard, these tests may offer earlier insights into risk, allowing for proactive lifestyle and medical management.
ModerateQualifiesMEDIUM confidence
The top ranked AD-associated blood DMPs were located in DAPK1, GAS1, and NDUFS5. Furthermore, epigenetic age acceleration was shown to be associated with AD neuropathological markers such as neuritic plaques, diffuse plaques, and amyloid load in the dorsolateral prefrontal cortex.
Why this rating
Based on multiple studies, but results are mixed and require further validation in large prospective cohorts.
Source
DNA Methylation Biomarkers in Aging and Age-Related Diseases
Yasmeen Salameh et al. · Frontiers in Genetics · 2020
DOI 10.3389/fgene.2020.00171
narrative_reviewCited 334×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- DNA methylation-based epigenetic clocks serve as accurate biomarkers for predicting biological age, disease risk, and mortality, often outperforming traditional chronological age metrics.Good
- Specific DNA methylation alterations in blood (e.g., ABCG1, TXNIP, SLC30A8) can predict the onset of Type 2 Diabetes (T2D) prior to clinical diagnosis, offering a window for early detection.Good
- Epigenetic age acceleration, measured by DNA methylation clocks, is associated with increased risk of Cardiovascular Disease (CVD) and mortality.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →